Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR/Arnt-XRE, pathway

Biochemical and Biophysical Research Communications

Volumn 345, Issue 4, 2006, Pages 1350-1357

  Kwak, Mi Kyoung ^a,b   Kensler, Thomas W ^b  

^a Yeungnam University   (South Korea)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

26S proteasome; 3 Methylcholanthrene (3 MC); ARE; Bifunctional inducer; Expression; Nrf2; Reporter gene; XRE

Indexed keywords

26S PROTEASOME; 3 METHYLCHOLANTHRENE; HYPOXIA INDUCIBLE FACTOR 1BETA; PEPTIDASE; PROTEASOME; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SUBUNIT; INCUBATION TIME; MUTATION; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOLYTIC ACTIVE CORE SUBUNIT BETA 5; REPORTER GENE; WILD TYPE; XENOBIOTIC RESPONSE ELEMENT;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BETA-NAPHTHOFLAVONE; CELL LINE, TUMOR; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOBLOTTING; LUCIFERASES; METHYLCHOLANTHRENE; MUTATION; NF-E2-RELATED FACTOR 2; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRANSFECTION;

MURINAE;

EID: 33744899830     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.043     Document Type: Article

References (25)

1. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
2. Almond J.B., and Cohen G.M. The proteasome: a novel target for cancer chemotherapy. Leukemia 16 (2002) 433-443
3. Demasi M., and Davies K.J. Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism. FEBS Lett. 542 (2003) 89-94
4. Sitte N., Merker K., von Zglinicki T., and Grune T. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic. Biol. Med. 28 (2000) 701-708
5. Grune T., Reinheckel T., and Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB J. 11 (1997) 526-534
6. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 27 (2003) 678-699
7. Keller J.N., Gee J., and Ding Q. The proteasome in brain aging. Ageing Res. Rev. 1 (2002) 279-293
8. Holtz W.A., and O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278 (2003) 19367-19377
9. Sherman M.Y., and Goldberg A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29 (2001) 15-32
10. Halliwell B. Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. NY Acad. Sci. 962 (2002) 182-194
11. Demasi M., Silva G.M., and Netto L.E. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J. Biol. Chem. 278 (2003) 679-685
12. Gomes-Marcondes M.C., and Tisdale M.J. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett. 180 (2002) 69-74
13. Elkon H., Melamed E., and Offen D. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J. Mol. Neurosci. 24 (2004) 387-400
14. Meiners S., Heyken D., Weller A., Ludwig A., Stangl K., Kloetzel P.M., and Kruger E. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J. Biol. Chem. 278 (2003) 21517-21525
15. Kwak M.K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., and Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278 (2003) 8135-8145
16. Kwak M.K., Wakabayashi N., Greenlaw J.L., Yamamoto M., and Kensler T.W. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol. 23 (2003) 8786-8794
17. Nioi P., and Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 555 (2004) 149-171
18. Mimura J., and Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta 1619 (2003) 263-268
19. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., and Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274 (1999) 26071-26078
20. Matsushita N., Sogawa K., Ema M., Yoshida A., and Fujii-Kuriyama Y. A factor binding to the xenobiotic responsive element (XRE) of P-4501A1 gene consists of at least two helix-loop-helix proteins, Ah receptor and Arnt. J. Biol. Chem. 268 (1993) 21002-21006
21. Rushmore T.H., and Pickett C.B. Xenobiotic responsive elements controlling inducible expression by planar aromatic compounds and phenolic antioxidants. Methods Enzymol. 206 (1991) 409-420
22. Prochaska H.J., and Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48 (1988) 4776-4782
23. Hensley K., and Floyd R.A. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch. Biochem. Biophys. 397 (2002) 377-383
24. Chondrogianni N., Stratford F.L., Trougakos I.P., Friguet B., Rivett A.J., and Gonos E.S. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278 (2003) 28026-28037
25. Anderson S.P., Howroyd P., Liu J., Qian X., Bahnemann R., Swanson C., Kwak M.K., Kensler T.W., and Corton J.C. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279 (2004) 52390-52398